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Background
Delirium and cardiac surgery
Postoperative delirium (POD) is an acute and typically 
reversible syndrome, characterized by a fluctuating level of 
consciousness and disturbances in attention and cognition1. 
Patients undergoing cardiac surgery are at especially high risk of 
developing POD2–9. The incidence of POD after cardiac sur-
gery is estimated to be between 20% and 70% depending on the 
population studied and the methods used to assess delirium2–9. 
Delirium has been described either as hyperactive or hypoac-
tive, the latter being more difficult to diagnose in the clinical 
setting than the former1. As one of the most common complica-
tions after cardiac surgery in older adults, POD is associated with 
prolonged length of hospital and intensive care unit (ICU) 
stay, increased morbidity and mortality, functional and cogni-
tive decline, and is often associated with placement in long-term 
care facility6,7,10.
Several non-modifiable risk factors at the time of surgery are 
associated with POD including age 60 years and older, pre-
existing cognitive impairment, psychiatric comorbidities, and 
low baseline regional cerebral oxygen saturation8,9,11–13. Possi-
ble precipitating risk factors specific to cardiac surgery include 
the type of cardiac surgery, cardiopulmonary bypass time, and 
the number of blood product transfusions7,9. The identification 
of potentially modifiable perioperative risk factors, for exam-
ple relating to the conduct of general anesthesia for cardiac 
surgery7, could positively impact this major health issue.
Electroencephalogram guided anesthetic management and 
delirium
While the use of processed electroencephalogram (EEG) indi-
ces to monitor depth of anesthesia is relatively prevalent in the 
anesthesiology community, these have mainly been directed 
towards avoiding patient awareness during surgery14–16. Recent 
interest has shifted to the potential for intraoperative EEG 
monitoring to prevent postoperative delirium17,18. The notion is that 
there might be specific EEG patterns that are strongly associated 
with POD, and these can be avoided through alterations in anes-
thetic management. One of these patterns is burst suppression, 
which is characterized by an isoelectric or suppressed EEG pat-
tern followed by a short burst of high amplitude activity. Burst 
suppression is considered to be “a strong synchronized out-
flow of thalamic discharges to a widely unresponsive cortex”19. 
Burst suppression is not encountered in normal physiological 
conditions such as sleep, but is associated with coma, induced 
hypothermia, some forms of epilepsy, cerebral hypoxia, 
and deep general anesthesia20. Both the occurrence of burst 
suppression and the cumulative duration of EEG suppression 
during general anesthesia have been associated with POD, but 
without clear evidence for causality3,21,22. The risk for burst sup-
pression during general anesthesia might be increased by older 
age, medical comorbidities, a greater intraoperative dose of 
benzodiazepines, and, most importantly, increased intraoperative 
volatile or intravenous anesthetic concentration3,21. The combi-
nation of EEG suppression and hypotension has been associated 
with increased mortality at 90 days post-surgery23. We therefore 
hypothesized that intraoperative guidance of anesthesia with 
the aim of avoiding or minimizing EEG suppression could 
decrease the incidence of POD in cardiac surgery patients. Evi-
dence for this hypothesis is bolstered by recently published 
meta-analyses of randomized trials, which reported that using 
a processed EEG monitor to guide anesthetic administration is 
likely to substantially decrease the incidence of POD7,24,25. While 
a recent randomized controlled trial using a strategy to avoid 
EEG suppression in older adults undergoing major surgery 
was not shown to be effective in decreasing the incidence of 
POD26, this strategy has not been tested specifically in older 
cardiac surgery patients, a population with many risk factors 
and a high incidence of POD.
The ENGAGES-Canada study: potential impact
The intent of the ENGAGES-Canada study is to determine if 
EEG-guided anesthesia to reduce anesthetic agent administration, 
thereby minimizing episodes and durations of EEG suppres-
sion, can effectively decrease the incidence of POD and its 
downstream sequelae in patients undergoing cardiac surgery 
(Table 1). The approach of minimizing periods of EEG sup-
pression specifically during cardiac anesthesia has not been 
previously tested in a large clinical trial. Recently published 
meta-analyses have suggested that EEG guidance of anesthe-
sia decreases the incidence of POD by more than a third25. If 
this result is reproduced in subsequent rigorous clinical trials, 
it will have important implications for how anesthesia is 
administered – especially to older adults. On the other hand, 
premature implementation based on the existing preliminary 
evidence might have unintended negative consequences. It is 
within this context that the ENGAGES trial and ENGAGES- 
Canada will provide critically clarifying information27,28. The 
ENGAGES trial addressed the question in unselected older 
adults undergoing major surgery26. ENGAGES-Canada will 
address the question specifically in cardiac surgery patients, 
where the risk of POD is especially high2–9.
Thus, the objective of the ENGAGES-Canada trial is to address 
whether reducing anesthetic administration based on EEG infor-
mation during cardiac surgery primarily decreases the incidence 
of POD, and secondarily decreases the duration and severity 
of POD. Other relevant measures in the trial will be clinically 
relevant outcomes determined at the index hospitalization, at 
approximately 30-day postoperatively, and at approximately 
1-year postoperatively.
Methods
Overview of the research design and study subjects
The Research Ethics Boards of the Montreal Heart Institute 
(2017-2164), the University of Manitoba (HS18290), Kingston 
University (ANAE-298-16), and the University of Toronto 
(17-5933) all approved the study. The details of the design of 
the ENGAGES-Canada study are included in this protocol and it 
contains the complete list of elements from the SPIRIT (Stand-
ard Protocol Items: Recommendations for Interventional Trials) 
checklist29,30. This study was registered with ClinicalTrials.gov 
(NCT02692300) on 26 February 2016.
The ENGAGES-Canada will randomize 1200 patients of 60 
years old and older in a clinical trial designed to be prag-
matic. The first patient randomized in the trial was enrolled in 
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November 2016. Competent patients who provide informed 
consent and who are undergoing elective cardiac surgery with 
cardiopulmonary bypass are eligible to be included in the study. 
There are no absolute contraindications to EEG monitoring, 
and the design of the ENGAGES-Canada trial is largely prag-
matic. Exclusion criteria include positive preoperative delirium 
screening. In addition, patients with hearing impairment, and 
those who are blind, illiterate, or do not speak French or Eng-
lish will be excluded because they will not be able to participate 
adequately in delirium screening. Finally, patients who have 
previously had general anesthesia and who have reported 
experiencing intraoperative awareness will also be excluded31.
Participants are randomized to either one of two groups: in the 
guided group, anesthetic administration is guided largely by 
EEG waveform; in the other group, patients receive current 
usual anesthetic care for cardiac surgery. Delirium and other 
assessments take place preoperatively, and delirium is assessed 
postoperatively from day one to five while the patient is in the 
hospital. The primary outcome will be the incidence of 
postoperative delirium. As secondary and other outcomes, we 
will also examine stress reaction and dissociation at discharge 
as potential factors associated with delirium and predictors of 
postoperative psychiatric symptoms. At 30-days and at 1-year, 
follow-up assessments include the quality of life as related to 
health, cognitive functioning, and information on psychiatric 
symptoms and on the incidence of falls – collected via self-report.
Recruitment
All patients in the study are asked to sign an informed consent 
(see extended data32). Subjects are recruited through the Pre-
Anesthesia Clinics, and baseline questionnaires are given at that 
time if they agree to participate. Perioperative clinics are staffed 
with anesthesiologists and nurses specialized in periopera-
tive medicine to evaluate the perioperative risks of each patient. 
Patients can also be enrolled prior to surgery in hospital 
wards during the preoperative visit.
Based on data from previous clinical trials including those focused 
exclusively on cardiac surgery2,8, we expect the study population 
to be largely balanced based on sex and there is no stratification 
of randomization by sex. Older and more vulnerable patients 
are often under-represented in clinical research. The patients 
enrolled in the trial should constitute a broad representation 
of older adults undergoing cardiac surgery in Canada.
Randomization and blinding
Computer-generated assignment at the patient level is used 
for randomization. Patients who are eligible, and have given 
informed consent, are randomized to either usual care or to the 
protocol for guided anesthesia according to the EEG. A one 
to one ratio of randomization of the patients between usual 
care and the protocol for EEG-guidance is used. Within the 
research team, members are trained to enroll participants and 
assign the randomization between the usual care or the protocol 
Table 1. ENGAGES-Canada: Conceptualization – Intervention, Mediators, Outcomes, and Adverse Events. Assessment acronyms: 
EEG – Electroencephalogram; ICU – Intensive Care Unit.
ENGAGES-Canada: Conceptualization
Intervention ·EEG-guided reduction of anesthesia 
Mediators 
 
• Hypothetically linked both to the intervention as well 
as to the outcomes and the adverse events
·Intraoperative mediators 
    ○Decrease in EEG suppression 
    ○Decrease in anesthetic exposure 
    ○Decrease in hypotension
Primary Outcome ·Incident postoperative delirium 
Exploratory Secondary Outcomes ·Length hospital and ICU of stay
Other Exploratory Outcomes ·Postoperative falls incidence and association between delirium and falls 
·Delirium duration and severity 
·Postoperative quality of life  
·Perioperative distress and dissociation ·Other delirium outcomes: delirium on 
day 0, time to delirium onset, sensitivity analyses, covariate adjustment 
· intraoperative mediating events: anesthetic concentrations, 
electroencephalogram suppression time and hypotension duration 
·Functionality 
·Cognition
Major Perioperative Adverse Events ·Undesirable movement 
·Awareness with recall 
·Serious complications (examples: major blood loss and transfusions, stroke, 
sternal wound infection, sepsis, dialysis, prolonged intubation) 
·Death
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for EEG-guidance. Anesthesiologists and their team learn of the 
group assignment after the patient is brought into the operat-
ing room; an opaque, sequentially numbered, sealed enve-
lope is opened to reveal the study group. The randomization 
sequence is generated by the data analysis center. The anesthe-
siologist and the team caring for the patient intraoperatively are 
not blinded to the group assignment. The patients and family 
members are not aware of the group assignment. The research 
team members who are in charge of the assessment of delir-
ium postoperatively remain blinded to the group assignment. 
Chart reviews are conducted by individuals blinded to the 
group assignment and blinded to the outcome of the postop-
erative delirium assessments29,30. Predictability of the rand-
omization sequence is minimized by recording in a separate 
document, unavailable to the members of the research team who 
enroll participants and assign groups, the details of patients 
who have already been randomized.
Protocol for EEG-guided anesthesia
Patients randomized to the EEG-guided group undergo 
anesthesia based on a pragmatic protocol to guide anesthesia 
administration according to EEG information. Prior to study 
participation, anesthesiologists are trained to recognize the 
typical EEG patterns of the different levels of anesthesia seen 
during anesthesia with volatile anesthetic agents; from the 
pattern in awake patients to the pattern typically found dur-
ing general anesthesia. Practitioners are also encouraged to 
complete the online training provided on the website www.
anesthesiaEEG.com as well as to watch two educational mod-
ules on the website www.icetap.org: one on waveforms of 
EEG and depth of anesthesia, and the other on Clinical deci-
sion making in anesthesia using the EEG. For sites using BIS 
processed electroencephalogram monitors, the proprietary proc-
essed BIS value is used in the EEG-guided group for the trial, 
as well as the raw waveforms of the EEG and all the numeri-
cal values seen on the monitor that are non-proprietary. These 
include the spectral edge frequency and the burst suppres-
sion ratio. For sites using a SedLine® monitor, the processed 
Patient State Index (PSi) in the EEG-guided group is used as 
well as the raw EEG waveform, spectrograms and suppression 
ratio. For sites using the NeuroSENSE® monitor, the processed 
WAVcns in the EEG-guided group is used as well as the raw 
EEG waveform, spectrograms and suppression ratio. To see 
clearly the low frequency slow delta waves, the EEG filter 
is turned off. If there is too much artifact in the EEG signal, 
practitioners may intermittently turn on the EEG filter to 
improve the resolution of the EEG trace. The anesthesiolo-
gists and their team are advised to inspect the waveform of the 
EEG to detect when there are periods of EEG suppression. EEG 
suppression can usually be recognized easily, and this pattern 
represents the main trigger, according to the protocol, for 
decreasing anesthetic administration. The low alarm is set at a 
value of 40 on the BIS monitor and NeuroSENSE® monitor or 
25 on the SedLine® monitor. The sounding of this low alarm 
indicates an increased risk of a burst suppression pattern on 
the EEG (see PSI 25-50 white paper)33. EEG index values less 
than manufactures’ recommendations (BIS and WAVcns values 
less than 40 or a PSi less than 25) indicate a second trigger for 
decreasing the administration of anesthetic agents. It is important 
to remember that the protocol of guidance of anesthesia 
according to the EEG waveform is suggestive and not pre-
scriptive. Clinical judgment can inform deviations from the 
protocol according to the specific situations encountered. For all 
patients, regardless of the allocation group, the low volatile alarm 
(0.3 minimum alveolar concentration or clinician’s discretion) 
sounds to decrease the risk of intraoperative awareness. In the 
usual care group, the EEG monitor values are masked from the 
anesthesia team, except for the signal quality measures, and 
the data are stored for analysis of epochs of EEG suppression. 
For sites using the BIS monitors and NeuroSENSE® monitors, 
anesthesiologists see the signal quality index (SQI) only and 
for sites using the SedLine® monitor practitioners only see the 
impedance quality of the electrodes.
Anesthesiologists fidelity to the EEG-guided anesthetic 
protocol
Monitoring devices can only influence and change clinical prac-
tice if important and useful information can be used by clini-
cians to make decisions regarding patient treatment during a 
case. Motivation to make decisions and act upon data from a 
monitoring device relies on familiarity with the device as well 
as evidence relating to outcomes. The use of EEG guidance 
of anesthesia in clinical practice is limited by the fact that elec-
troencephalography is not formally part of the current residency 
curriculum. It is therefore not surprising that EEG guidance of 
anesthesia has not been adopted into usual anesthetic care. 
Focused training sessions have shown that anesthesiologists 
can readily learn the changes in EEG waveform associated 
with sedation and general anesthesia34. Clinicians are capa-
ble of integrating the information from the EEG waveform 
when provided with clinical context and of estimating the BIS 
values associated with specific EEG waveforms34. Arising from 
the results of this study, an international non-profit initiative 
focused on EEG education was launched: International Con-
sortium for Electroencephalograph Training of Anesthesia 
Practitioners.
Teaching the EEG waveform to anesthesiologists at our institu-
tions and emphasizing the role of EEG in the guidance of anes-
thetic management are crucial ingredients to the success of the 
ENGAGES-Canada study. EEG derived parameters are captured 
electronically. This includes both the proprietary values, such as 
the BIS, WAVcns and PSi values, and non-proprietary values 
such as the suppression ratio. As a proof of concept, we were 
able to show in the first 102 patients enrolled to the ENGAGES-
Canada trial that there was a reduction in both cumulative EEG 
suppression time and volatile anesthetic administration in the 
patients randomized to EEG-guided anesthetic care. Since 
our fundamental hypothesis for the ENGAGES-Canada study 
is that, in real-world practice, alterations in the manage-
ment of anesthesia guided by the EEG waveform can prevent 
postoperative delirium, a crucial step was to confirm the abil-
ity of cardiac anesthesiologists to decrease the duration of EEG 
suppression by following the EEG-guided protocol.
Outcomes
The primary outcome is the occurrence of incident delirium on 
postoperative days 1-5. Secondary outcomes include: length of 
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ICU and hospital stay; duration and severity of delirium POD 
1-5; incidence of falls and association between delirium and 
falls at 30 days and at 1 year; association between delirium and 
quality of life by PROMIS Global Health; predictors of Post-
Traumatic Stress Disorder (PTSD) by PDEQ at 5 days and 30 
days postoperatively; and predictors of Post-Traumatic Stress 
Disorder (PTSD) by PDEQ at 5 days and 30 days postopera-
tively. Exploratory outcomes include co-variates of delirium, 
functionality, and cognitive impairment at 30 days and at 1 year 
postoperatively. Pre-specified exploratory analyses include intra-
operative mediating events such as anesthetic concentrations, 
electroencephalogram suppression time, and hypotension 
duration. Perioperative adverse events include undesirable intra-
operative movement, awareness with recall, complications 
such as major blood loss and transfusions, stroke, sternal wound 
infection, sepsis, dialysis, prolonged intubation, and mortality 
rates at 30-day and at 1-year.
Data collection
Preoperative
Preoperative assessments are performed in the Pre-Anesthesia 
Clinic or hospital ward. These include demographic informa-
tion and medical history, assessment of preoperative quality of 
life, psychiatric symptoms (i.e., anxiety, depression, alcohol use, 
trauma history, and posttraumatic stress disorder), objective and 
subjective cognitive functioning measures35,36, and evaluation 
of falls’ history. The purpose of the preoperative assessments 
is to identify cognitive and psychiatric disorders in order to 
better understand risk factors for postoperative delirium and its 
sequelae. For example, postoperative delirium has been asso-
ciated with impaired performance on preoperative cognitive 
tests37, and postoperative delirium predicts persistent postop-
erative cognitive decline6. These known risk factors will be 
included in covariate analysis for the primary outcome and 
will be used in exploratory analyses. The following measures 
were selected for the assessment of cognitive and psychiat-
ric symptoms based on their brevity, frequency of use in medi-
cal practice, validity for older adults, and lack of copyright 
restrictions: (1) 8-item AD8 Dementia Screen38, (2) History of 
Delirium Screen, (3) Short Blessed Test39, (4) 3-item Alcohol 
Use Disorders Identification Test (AUDIT-C), (5) 1-item surgi-
cal anxiety visual analogue scale, (6) Trauma History Screen, 
(7) Posttraumatic Stress Disorder Checklist (PCL-5; past-month 
PTSD assessment), (8) 4-item Primary Care PTSD Screen 
(PC-PTSD; lifetime PTSD assessment), (9) 4-item Patient 
Health Questionnaire (PHQ-4; anxiety and depressive symp-
toms), (10) 10-item Patient Reported Outcomes Measure-
ment Information System (PROMIS) Global Health (physical 
and mental health related quality of life), (11) 4-item PROMIS 
Applied Cognition-Cognitive Concerns, (12) 4-item PROMIS 
Applied Cognition-Abilities (see extended data32). Patients will 
also receive a questionnaire regarding history of falls. Baseline 
screening, informed consent, delirium assessments (described 
below), and self-report symptom measures take approximately 
30-40 minutes. Research assistants obtain informed consent and 
administer AD8 Dementia Screen, History of Delirium Screen, 
Confusion Assessment Method (CAM long form; detailed below), 
and the Short Blessed Test; the remaining surveys can be com-
pleted independently if the patient has the capacity to do so. A 
script is provided to research assistants to introduce the psychi-
atric symptom measures (extended data32). If patients request a 
direct referral for mental health related issues, they are referred 
to the appropriate clinician by the attending anesthesiologist 
in the Pre-Anesthesia Clinic.
Perioperative period (up until discharge)
Delirium and pain are assessed postoperatively in the afternoon/
evening while patients are in the hospital. Daily delirium assess-
ments collected specifically for the ENGAGES-Canada study 
are entered into the Washington University School of Medicine 
Research Electronic Data Capture (REDCap)40 database. EEG 
data, including BIS values, WAVcns, PSi values, and duration of 
EEG burst suppression are collected in both the guided as well as 
in the usual care group. In the usual care group, anesthesiolo-
gists are blinded to EEG data41,42. Perioperative data, includ-
ing the repeated measures data, are saved for analysis from the 
intraoperative electronic data capture. As part of the routine 
data collection, we obtain for each patient a detailed medical 
history, surgical history, specific risk factors, medications, 
Blessed Dementia rating scale, screening for sleep apnea, 
laboratory values, medications during surgery, physiological 
readings, and parameters from the postoperative recovery 
period. At the time of discharge, patients will also complete a 
measure of immediate stress reactions (13-item Peritraumatic 
Distress Inventory; PDI) and peritraumatic dissociation (10-item 
Peritraumatic Dissociative Experiences Questionnaire; PDEQ) 
in the perioperative period, which have been found to be strong 
predictors of incident psychiatric disorders immediately following 
the stressful experience. Furthermore, they will complete an 
adapted 4-item PHQ-4 concerning more general anxiety and 
depressive symptoms, specifically during the perioperative period. 
These tests take patients approximately 5 minutes in addition 
to their CAM long form assessment (10 minutes).
Postoperative delirium
The primary outcome of the study is the incidence of post-
operative delirium. Assessment of postoperative delirium is 
conducted in patients that can be sufficiently aroused according 
to a Richmond Agitation and Sedation Score ≥ -3. Assessment 
of patients for delirium is performed from day one to day 5, 
once daily, in the afternoon/evening. A diagnosis of delirium 
for each patient is based on an approach combining a standard-
ized daily assessment with a structured chart review. Members 
of the research team who are blinded to the treatment arm 
of the study assess patients for delirium using the Confusion 
Assessment Method (CAM long form)43, or the Confusion 
Assessment Method for the Intensive Care Unit (CAM-ICU)44,45 
for patients who are unable to speak (e.g., have a tracheal tube 
or tracheostomy). The CAM long form is deemed a viable tool 
that can be used by non-psychiatrists and by non-mental health 
professionals for delirium detection43. The CAM long form 
has subsequently been validated in a number of studies and 
against a reference standard, with a sensitivity of >94% and a 
specificity of >89%46. The CAM long form and the CAM-ICU 
are reliable instruments in good agreement with the DSM-IV 
criteria for delirium45,47,48. To complete the delirium assess-
ment of patients, a trained clinical researcher blinded to the 
CAM results and group assignment conducts a structured chart 
Page 6 of 16
F1000Research 2019, 8:1165 Last updated: 24 SEP 2019
reviews for delirium detection. A positive CAM long form, or 
CAM-ICU, or chart review delirium detection49,50 is deemed 
sufficient and necessary to diagnose incident delirium in the 
ENGAGES-Canada trial. The approach combining a CAM long 
form interview, or a CAM-ICU, plus a chart review results in an 
increase in the sensitivity while retaining specificity in detect-
ing incident delirium49,50. In addition, use of a chart review 
bolsters the pragmatic aspects of this trial, since it obtains infor-
mation from a readily available source. Determination of delir-
ium severity is based on the CAM-S long form measure or the 
CAM-ICU-7 Delirium severity instrument51,52.
The CAM long form assessment that is used in the trial was 
developed by Dr. Inouye and colleagues43, and includes a brief 
cognitive battery. All study team members who perform delir-
ium assessments undergo a structured training process. For the 
initial training, representatives from the research team partici-
pated in a full-day training program led by Dr. Inouye, the original 
creator of the CAM long form53. Those who attended this 
initial training are overseeing the training of other team mem-
bers. Trainees must demonstrate competence at both conduct-
ing CAM long form and CAM-ICU interviews and in scoring 
these interviews. To establish their ability to score CAM long 
form interviews, trainees accompany trained team members to 
conduct CAM long form interviews. A trained member of the 
research team conducts each CAM long form interview for 
patients enrolled in the trial. The trainee observes the inter-
view, but scores the CAM long form independently. The 
trainee must agree with the trainer on the presence or absence 
of all 12 cognitive features assessed by the CAM long form 
on a minimum of two delirious and two non-delirious patients. 
After meeting the stipulations of training, the newly trained team 
member will conduct their first interview of a patient enrolled 
into the trial in the presence of a previously trained team 
member. Independently of the training, all team members 
who are participating in CAM long form assessments must 
view and rate nine videos of standard interviews of actors 
depicting delirious and non-delirious patients. Research team 
members must be trained on CAM long form assessments prior to 
completing any structured delirium chart reviews.
This structured process is employed to evaluate and confirm the 
quality of the assessments of delirium. In all cases the assess-
ments of delirium are reviewed within three days by a fellow 
member of the research team to evaluate internal consistency 
of scoring and completeness. Once a month, all challenging 
delirium assessments are discussed in a conference call includ-
ing investigators from all sites. Whenever there is ongoing 
disagreement regarding a CAM long form, CAM-ICU or delir-
ium chart review, these are allocated to experts for adjudication 
(involving ES, SI). Ongoing interrater-reliability assessments 
of all study staff are planned annually. A random selection 
of CAM long form, CAM-ICU, and structured chart reviews 
are sent to experts for quality control purposes.
30-days postoperative
Self-report psychiatric and cognitive symptom measures are 
either mailed to patients 30-days post-surgery with a stamped 
and addressed return envelope, sent by e-mail, or obtained 
through a telephone call. The following measures are re-admin-
istered: Falls Questionnaire, AUDIT-C, PDEQ, PCL-5, PHQ-4, 
PROMIS Global Health, PROMIS Applied Cognition-General 
Concerns, and PROMIS Applied Cognition-Cognitive Abilities. 
These tests take approximately 15 minutes for patients to 
complete.
1-year postoperative
Self-report psychiatric and cognitive symptom measures are 
either mailed to patients 1-year post-surgery with a stamped and 
addressed return envelope, sent by e-mail, or obtained through 
a telephone call. The following measures are re-administered: 
Falls Questionnaire, AUDIT-C, PCL-5, PHQ-4, PROMIS 
Global Health, PROMIS Applied Cognition-General Concerns, 
and PROMIS Applied Cognition-Cognitive Abilities. Addi-
tionally, patients are contacted via phone and receive the Short 
Blessed Test. These tests take patients approximately 15 minutes 
to complete by writing. The phone call for the Short Blessed Test 
lasts approximately 3 minutes.
Sample size calculation statistical analyses
Based on previous studies in cardiac surgery patients, we con-
servatively estimated a delirium incidence in the control group 
of 25%2–9 and based on meta-analyses of randomized trials 
we estimated a relative reduction in delirium with guidance of 
anesthesia based on EEG waveform of more than one-third3,7,24. 
Assuming a two-sided alpha <0.05 and 1200 patients, we 
estimated >90% power to be able to detect an absolute decrease 
in the incidence of delirium of 8%27. With a more stringent 
two-sided alpha <0.005, we estimated >70% power. We antici-
pate that most patients will be available for primary outcome 
ascertainment (i.e. incident postoperative delirium assessment). 
Continuous variables will be presented as mean (SD) or median 
(interquartile range [IQR]), depending on their distributions. 
Chi-square or Fisher’s exact tests will be used for compari-
sons of discrete data. Unpaired Student’s t or Mann–Whitney 
U tests will be used for comparisons of continuous data, depend-
ing on their distributions. Confidence intervals for median dif-
ferences will be calculated using Hodges-Lehmann estimates, 
and for differences between proportions we will use New-
combe’s method with continuity correction54. For the primary 
outcome, the proportion of patients with incident postoperative 
delirium will be compared between the two study groups. We 
will conduct three post-hoc sensitivity analyses to assess whether 
improved clinician fidelity to the guided protocol might alter the 
primary outcome. Within the guided group 25% of cases will 
be excluded with the (1) longest cumulative electroencepha-
logram suppression time; (2) longest cumulative time with 
BIS, WAVcns <40 or PSi <25; and (3) highest median volatile 
anesthetic concentrations. To compare time to delirium onset 
between groups, we will construct Kaplan-Meier curves for each 
group and conduct a log-rank test. We will perform a covariate 
adjustment including likely risk factors for delirium (including 
age, sex, history of depression, history of delirium, AD* Test, 
Short Blessed Test, comorbidity index, and study center) using 
two methods: (1) logistic regression and (2) standardized 
estimator combined with bootstrapped 95% confidence intervals 
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(CIs)55. We will compare delirium incidence between groups, 
segregated by Charlson Comorbidity Index categories56. 
Patients will be assessed based on their randomization group in 
accordance with an intention-to-treat approach. We will also con-
duct a per protocol sensitivity analysis: when clinicians in the 
usual care group view EEG data, these patients will be included 
in the guided group; and where there are technical difficulties 
in viewing electroencephalogram data in the guided group, these 
patients will be included in the blinded group. Patients who can-
not be assessed for delirium will be excluded from the primary 
outcome analysis. In two sensitivity analyses, these patients 
(unless they die during surgery) will either all be assumed 
to have had incident delirium or not to have had incident 
delirium. We will compare preoperative characteristics between 
respondents and alive non-respondents to 30-day postoperative 
surveys. We will do the same for the 1-year postoperative sur-
veys. Results will be presented with 95% CIs. All significance 
testing will be two-sided, with P values <0.05 considered as 
providing suggestive evidence and P values <0.005 as providing 
more compelling evidence57. The statistical analyses will be per-
formed with SAS, V.9.4 (SAS Institute, Cary, North Carolina) 
and/or STATA, V.14.2 (StataCorp LP, College Station, Texas).
Secondary outcomes (falls, quality of life, psychiatric 
status, cognitive functioning)
Estimations of the primary outcome (incidence of delirium) 
was used for the calculation of the overall sample size of our 
study. For secondary analyses, it is assumed that 80% (∼1000 
patients) of the trial population will have completed the 30-day 
and 1-year follow-up survey. With a sample size of 1000 
patients, it should be possible to detect a difference of 0.5 points 
(SD of 2.5) in mean score of the Physical Health Score from 
baseline to 30-day and 1-year follow-up survey between the 
usual care and guided group with a power of >80% and a 
2-sided alpha level of p<0.05. Secondary outcomes and explora-
tory analyses will be examined in a number of ways; including 
multivariable regressions.
Strengths of the study and limitations
Strengths. Several important strengths can be ascribed to the 
ENGAGES-Canada study. The clinical trial is randomized, 
pragmatic, includes high volume sites, and is conducted in 
real life settings. The interventions to avoid EEG suppres-
sion are easily implemented and the primary outcome, the inci-
dence of delirium, is of tremendous importance to patients, 
health care systems and society. In relation to the primary out-
come (delirium incidence), the CAM instrument has been 
validated against reference standard DSM-IV and DSM-IV-
TR criteria in multiple studies, and has been appraised as one 
of the two most reliable instruments for detecting delirium 
in a research context58. The CAM long form has been 
demonstrated to have excellent psychometric properties for both 
hypoactive and hyperactive delirium59. Programmatic training, 
coupled with the highly structured use of the CAM long form 
(as we are doing in the trial), has demonstrated excellent inter-
rater reliability of researchers28,60. In addition, by complement-
ing the CAM long form (or CAM-ICU) with validated chart 
review50, we are bolstering delirium detection and minimizing 
missing primary outcome assessments. Since many components 
of the study are already incorporated into existing processes 
and infrastructures at participating Canadian sites, its implemen-
tation can be efficient. Enrollment is easily achieved within the 
flow of the clinic. The study is largely conducted by anesthe-
siologists and is integrated into the course of their clinical 
workday. Randomization is implemented in the operating room 
at the point of patient care because the anesthesia protocols do 
not require any advanced preparation or lead-in time. Enrollment 
of vulnerable patients 60 years old and older allows us to 
study a population that is understudied in clinical research. 
The importance of studying and understanding this 
targeted population lies in the potential of significant benefits 
from reducing the incidence of postoperative delirium and its 
related outcomes. Secondary outcomes such as patient-reported 
health-related quality of life factors are especially relevant to 
older patients who remain a largely understudied population. 
Trial feasibility is enhanced by the participation of investigators 
from multiple disciplines, who as a group has managed to estab-
lish a track record of successful collaboration and the comple-
tion of several major clinical trials (Canadian PACT group61–63). 
Since EEG guidance of anesthesia is straightforward and inex-
pensive, positive results from the study could provide strong 
effectiveness evidence, and would facilitate implementation, 
sustainability and dissemination of the EEG-guided protocol 
on a national level in Canada, as well as in other countries.
Limitations. Some limitations for the trial should be con-
sidered. The EEG-guided protocol can only be effective if 
anesthesiologists adhere to it. Including patients in a clinical 
trial aiming at the prevention of the incidence of postopera-
tive delirium and providing patients and family members with 
educational material on the subject could possibly decrease 
the incidence of postoperative delirium. Three methods of 
assessment will be used to diagnose postoperative delirium, a 
pragmatic structured chart review, the full CAM and the CAM-
ICU. The CAM-ICU has a decreased sensitivity compared 
to the CAM long form. However, the CAM-ICU is broadly 
used and has been validated for patients who are unable to 
speak (i.e., with a tracheostomy or a breathing tube in place). 
Available data from participating centers indicate that the vast 
majority of patients enrolled in the in the study will be extubated 
within the first 48 hours. As a result, delirium assessment will 
usually be obtained with the more specific and sensitive instru-
ment – the CAM long form. Since the 30-day and the 1-year 
follow-ups for patient are based on self-report outcome measures, 
a potential limitation is an incomplete follow-up at these peri-
ods in time. Consequently, a sensitivity analysis was performed 
in our power calculations to take into account this possible 
attrition (80% response rate at 30-day and at 1-year). We plan 
to improve follow-up by contacting patients first by mail and, if 
unsuccessful, by e mail or telephone calls. Postoperative delir-
ium could be missed with recurrent assessments because it is 
well known to be a fluctuating disorder. In our efforts to mini-
mize missed diagnosis of postoperative delirium, we have 
included a structured chart review. This validated comple-
mentary approach has been shown to increase the detection of 
postoperative delirium49,50.
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Potential risks, alternatives and benefits
Benefits. If our hypotheses are confirmed, patients rand-
omized into the group with the EEG-guided anesthesia will 
have a greater chance of avoiding postoperative delirium and its 
consequences’ downstream; including decrement in quality of 
life, falls, and cognitive decline. Evaluation of any potential unan-
ticipated negative effects of EEG-guidance by investigating this 
range of psychiatric, cognitive, and functioning outcomes will also 
be possible.
Risks. There are few risks associated with this study. Breach of 
confidentiality is a rare risk. Psychiatric symptom self-report 
measures may also cause patients temporary distress, but it may 
also provide the opportunity for distressed patients to obtain 
community mental health resources and/or appropriate referral. 
EEG guidance of anesthesia poses a theoretical risk of intraop-
erative movement and/or awareness with recall. Nevertheless, 
previous studies have not found an increased incidence of 
awareness with randomization of patients to protocols using EEG 
guidance of anesthesia14,15,64. In our study, intraoperative aware-
ness with recall will be tracked within 48 hours of extubation 
postoperatively with a modified Brice interview65 (see extended 
data32). Review of adverse events by a data-safety monitoring 
committee and the PI, in consultation with the institutional 
review board, might lead to the recommendation to stop the trial 
in the event of increased reporting of intraoperative awareness in 
the EEG-guided group. In the informed consent for this study, 
patients are made aware of the rare risk of intraoperative aware-
ness with recall. Serious side effects will be reported to the 
Ethics Committees and to the study’s data safety monitoring 
board. There is no financial compensation for the participating 
patients and all expenses related to the study are incurred by the 
participating research sites.
Minimizing risks and confidentiality
Members of the research team will share protected and nec-
essary health information. Confidentiality will be protected 
by storing charts in locked cabinets located inside locked 
research offices. Demographic information and electronic 
data will be password-protected on an electronic database and 
will be stored on the network drive of the participating sites. 
Computers accessing this network will also be password-
protected. This information will be entered by a designated 
member of the research team. The documents and data used 
for evaluation or statistical analyses will only contain coded 
numbers. Patients are free to decline participation in the study 
without penalties for the care they receive. Data management and 
processing will be done by the Division of Biostatistics 
Informatics Core at Washington University. Washington Univer-
sity is part of a consortium of institutional partners working to 
provide clinical trial data and management of research through 
a software toolset and workflow methodology for electronic 
collection. REDCap (Research Electronic Data Capture) data 
collection projects rely on a thorough study-specific data 
dictionary defined in an iterative self-documenting process by 
all members of the research team with planning assistance from 
the Division of Biostatistics Informatics Core. A well-planned 
data collection strategy for individual studies results from 
an iterative development and testing process. REDCap serv-
ers are securely housed in an on-site limited access data center 
managed by the Division of Biostatistics at Washington Univer-
sity. All web-based information transmission is encrypted. The 
data is stored on a private network, firewall-protected. Individual 
user identifiers and passwords are given to all users with restricted 
access depending on the specific role in the study. REDCap was 
developed specifically around HIPAA-Security guidelines, and 
is implemented and maintained according to University guide-
lines. More than 500 academic and/or non-profit consortium are 
supported by REDCap on 6 continents and 38,800 research 
end-users.
Safety monitoring and adverse event reporting
Adverse events during the study will be monitored by the 
research team. If a serious adverse event (SAE) occurs, it will 
be directly reported to the REB in accordance with REB stipula-
tions. For this pragmatic study, the safety monitoring plan seems 
appropriate. We conducted three large clinical studies where 
EEG-guided general anesthesia was given to half of the 28,000 
patients studied. From these studies, no adverse events were 
attributable to EEG-guided anesthesia14,15,64. There is there-
fore no reason to think that adverse events attributable to EEG-
guided anesthesia would occur in the present study. Since this 
is a low risk trial, the study has an appropriate data and safety-
monitoring plan. The Data Safety Monitoring Board (DSMB) 
provides oversight of the ENGAGES-Canada Clinical Trial. The 
DSMB will examine data for the safety of the participants and 
will review the general conduct of the study66. Recommenda-
tions will be made by the DSMB regarding the modification, 
continuation, or termination of the study67. The expertise of 
the DSMB members will allow examination the cumulative 
data, protection of the integrity of the clinical experiments to 
which the patients have consented to participate, and to assure 
the regulatory bodies and the public that conflicts of interest 
do not compromise either patient safety or trial integrity68. An 
annual review of the safety events will be conducted by the 
DSMB. The DSMB may advise to stop the trial for safety con-
cerns, but not for reasons of efficacy or because of futility66. 
Implausibly large treatment effects are found in trials that stop 
early for benefit, especially with small number of events69. Trials 
that have terminated early show greater effect sizes compared 
to trials that are continued, independent of existing statistical 
rules for terminating the trial70.
Early stoppage of the trial. On average, we can assume that 
patients in the group with EEG-guided anesthesia will receive, 
on average, lower concentrations of inhaled anesthetic agents 
during surgery. Studies using similar strategies have been reported 
without increased incidents related to intraoperative awareness 
with recall71,72. Nevertheless, we cannot exclude the possibil-
ity that patients receiving lower concentrations of inhaled 
anesthetic agents could experience a higher incidence of intra-
operative awareness. Therefore, it will be necessary to compare 
the incidence of intraoperative awareness between groups 
in the trial. We recommend to the DSMB that this occurs at 
mid-point during the study (600 patients). Results from a 
one-tailed comparison of the incidences of awareness between 
the groups showing an increased incidence of awareness in 
the EEG-guided group (with a p value <0.05) will result in 
consideration by the DSMB to terminate the study. The sever-
ity of the awareness experiences; including reports of pain, 
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paralysis, and distress could be taken into consideration by the 
DSMB73. Furthermore, other measures of peritraumatic distress 
and dissociation are administered at discharge, which will further 
allow for an evaluation of severity of awareness. Besides 
intraoperative awareness, a lower administration of inhaled 
anesthetic agents is not hypothesized to result in adverse 
outcomes that would be clinically important such as death, 
myocardial infarction, and/or stroke. Other events that could 
be associated with decreased anesthetic administration include 
intraoperative patient movement and higher intraoperative blood 
pressure and/or heart rate. These measures have unclear clinical 
relevance if not related to more severe adverse events and, as 
such, should not influence the decision to stop the study early.
It is recommended that an interim efficacy analysis of EEG 
guidance should not be performed by the DSMB with respect 
to the primary outcome of incident delirium. Some data sup-
port the hypothesis that EEG-guided anesthesia decreases 
the incidence of postoperative delirium, but other data do not 
support this hypothesis7,72,74,75. A higher incidence of postopera-
tive delirium in the EEG-guided group would conflict with the 
results of current studies. The results of a partially completed 
trial would therefore be unlikely to provide compelling evi-
dence to influence future clinical practice for anesthesia guided 
by EEG waveform in this patient population.
Ethics and dissemination
All major changes to the protocol will be decided by the trial 
steering committee. The committee will communicate these 
changes to the REB and appropriate parties.
The final dataset of the trial is the property of the investigative 
team and shall not be shared without permission from the prin-
cipal investigator. Dissemination plans include presentations at 
local, national and international scientific conferences. Every 
effort will be made to publish results of the ENGAGES-Canada 
trial in a peer-reviewed journal. Dissemination of results to study 
participants and their family members will be available upon 
request. Updates and results of the study will be available to the 
public at www.clinicaltrials.gov.
Pre-specified additional analyses and sub-studies
Canadian centers participating in the ENGAGES-Canada 
Trial are encouraged to develop sub-studies related to the trial 
if approved by their local REBs. No sub-study can be pub-
lished prior to pre-approval by the ENGAGES-Canada Trial 
Management Committee.
a)    Association between delirium and clinically relevant 
outcomes
 The Engages-Canada trial will explore the associa-
tions between outcomes that are clinically relevant such 
as cognitive decline, falls, functional decline, ICU and 
hospital length of stay, and mortality; and the severity, 
incidence, and duration of delirium.
b)    Differences between observational and patient-reported 
pain scores
 Patients with postoperative delirium may lack the 
ability to express verbally the level of pain they are 
suffering76. Understanding that uncontrolled postoperative 
pain may be related to delirium emphasizes the impor-
tance of the assessment and treatment of postoperative 
pain. A comparison of behavioral pain assessment and 
patient reported pain will be made in delirious and 
non-delirious patients76. These pain scores can also be 
explored in the context of psychiatric status as high 
comorbidity rates exist.
c)    Patient outcomes and delirium
 The association between cognitive status, falls, and 
quality of life with postoperative delirium will be 
evaluated at 30-day and at 1-year post surgery.
d)    Anesthesia depth and postoperative outcomes
 Secondary measures, that can be related to the differ-
ence in anesthesia depth between the two groups of 
patients, will be evaluated since patients in the EEG-
guided group will almost certainly be exposed to lower 
concentrations of anesthetic agents. We will then be 
able to compare our results with an ongoing randomized 
clinical trial looking at the effects of depth of anesthe-
sia on a range of outcomes77, such as cardiac arrest, 
pulmonary embolus, death, stroke, myocardial infarction, 
cardiac arrest, surgical site infection, ICU and hospital 
length of stay, and intraoperative awareness.
e)   Post-traumatic stress disorder (PTSD) outcomes
 There is growing interest in understanding PTSD 
post-operatively given its high prevalence in surgical 
cohorts78. The current study allows for an incidence 
investigation, as a history of PTSD is assessed at base-
line. This study will allow for a thorough investigation 
using contemporary DSM-5 PTSD criteria. Incident 
PTSD at 30-day and at 1-year follow-up will be assessed 
and several potential mechanisms can be explored 
including: pre-operative factors, dissociation and 
distress during the surgical period, delirium, surgical 
complications, psychiatric and cognitive status, and depth 
of anesthesia.
f)    Decreases in Regional Cerebral Oxygen Saturation and 
EEG Suppression Patterns
 Some of the participating sites measure Regional 
Cerebral Oxygen Saturation (rSO2) on a regular basis. 
Several studies have shown an association between 
significant perioperative decreases in rSO2, cognitive 
decline, and postoperative complications62,79,80. We 
therefore intend to explore the relationship between EEG 
suppression and cerebral desaturations.
Study status
To date two interim analyses have been performed, one at 
240 patients and another at 570 patients. While randomization 
remains blinded, both analyses confirmed separation of the 
groups in term of total time in EEG suppression pattern 
(control group with more suppression) as well as a total incidence 
of delirium within the range of the predicted value used for the 
original power analysis.
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Strengths
•    The ENGAGES-Canada study is a multi-center clini-
cal trial, conducted with a pragmatic design to reflect the 
clinical setting encountered in real-life.
•    Cardiac surgery patients are at high risk for postoperative 
delirium.
•    Postoperative delirium is important to patients, healthcare 
providers, and society.
•    Guidance of anesthesia by electroencephalography is 
low-cost and could be broadly accepted.
•    As a secondary aim, this study will also include cogni-
tive and psychiatric outcomes 30-days and 1-year after 
surgery.
Limitations
•    The protocol-guiding anesthesia with electroencepha-
lography can only be effective if anesthesiologists adhere 
to it.
•    Delirium is a disorder that fluctuates in the course of 24 
hours. It can be easily missed with scheduled assessments, 
regardless of the rigor of these assessments.
•    When patients are unable to speak, delirium assessment 
might be less sensitive.
•    Incomplete follow-up at 30 days and 1-year postoperatively 
might limit some of the interpretations.
•    Self-reported cognitive and psychiatric symptom measures 
are less reliable than structured clinical interviews.
Data availability
Underlying data
No data is associated with this article.
Extended data
Open Science Framework. ‘Protocol for the electroencephalog-
raphy guidance of anesthesia to alleviate geriatric syndromes 
(engages-Canada) study: A pragmatic, randomized clinical trial’, 
https://doi.org/10.17605/OSF.IO/DXY2732 
This project contains the following extended data:
•    ENGAGES-CANADA Protocol Appendix.pdf (PDF 
file containing all study questionnaires and screening 
materials)
•    ENGAGES-CANADA Script.pdf (script for research 
assistants to introduce the psychiatric symptom measures)
•    ENGAGES-CARDIAC Conscent French.pdf (Consent 
form, French)
•    ENGAGES-CARDIAC Consent English.pdf (Consent 
form, English)
Reporting guidelines
Open Science Framework: SPIRIT 2013 checklist for ‘Protocol 
for the electroencephalography guidance of anesthesia to allevi-
ate geriatric syndromes (engages-Canada) study: A pragmatic, 
randomized clinical trial’, https://doi.org/10.17605/OSF.IO/
DXY2732 
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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